Clinical Trials
9 trialsNCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT01727427 2019-08-08
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
G. d'Annunzio University
Completed
NCT00381888 2017-12-28
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT01444612 2017-05-16
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
GlaxoSmithKline
Completed
NCT00539942 2017-03-27
Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
University of Alabama at Birmingham
Phase 3 Terminated
NCT00423683 2016-06-08
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism
Northwell Health
Phase 3 Terminated
NCT00659399 2015-03-18
Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression
NYU Langone Health
Phase 1 Withdrawn
NCT01267305 2014-04-29
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery
Shanghai Zhongshan Hospital
Phase NA Completed
NCT00476216 2014-03-05
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
University of Alabama at Birmingham
Phase 1 Completed